PDL BioPharma, Inc. EV/Sales

EV/Sales of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Sales growth rates and interactive chart. Compares the total enterprise value of a company to its sales. It is a more accurate measure of business value, as it takes into account cash and debt on the balance sheet. A company with large cash holdings and no debt will show a significantly lower EV/S than P/S ratio.


Highlights and Quick Summary

Current EV/Sales of PDL BioPharma, Inc. is 4.44 (as of December 30, 2019)
  • EV/Sales for the quarter ending June 29, 2020 was 4.25 (a 49.14% increase compared to previous quarter)
  • Year-over-year quarterly EV/Sales increased by 434.5%
  • Annual EV/Sales for 2019 was 4.44 (a 477.09% increase from previous year)
  • Annual EV/Sales for 2018 was 0.77 (a 687.82% increase from previous year)
  • Annual EV/Sales for 2017 was 0.1 (a -93.29% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Sales of PDL BioPharma, Inc.

Most recent EV/Salesof PDLI including historical data for past 10 years.

Interactive Chart of EV/Sales of PDL BioPharma, Inc.

PDL BioPharma, Inc. EV/Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 4.25 2.85
2019 4.44 0.8 1.63 1.45 4.44
2018 0.77 0.39 0.37 0.49 0.77
2017 0.1 0.36 0.2 0.4 0.1
2016 1.46 1.67 1.23 0.89 1.46
2015 0.99 1.65 1.82 1.69 0.99
2014 2.07 2.05 3.12 2.37 2.07
2013 2.69 2.16 2.29 2.86 2.69
2012 2.95 3.39 2.82 2.86 2.95
2011 2.67 2.45 2.59 2.44 2.67
2010 0.0 0.0 0.0 0.0

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.